• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVIS & GECK CARIBE LTD SURGITIE; SUTURE, ABSORBABLE, NATURAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVIS & GECK CARIBE LTD SURGITIE; SUTURE, ABSORBABLE, NATURAL Back to Search Results
Model Number EL-21-L
Medical Device Problem Code Unraveled Material (1664)
Health Effect - Clinical Code Pain (1994)
Date of Event 02/20/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
D10 concomitant product: el-21-l, el-21-l polysorb 0 vio 52cm tie wdx6 (lot#: j3g2671y).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
According to the reporter, postoperatively, of an laparoscopic appendectomy procedure, there was a release of two synthetic ligature loops due to the appendectomy, which resulted in peritonitis.It was noted that it was very painful for the patient.To resolve the issue, a closure of the appendicular stump was done by stapling.
 
Event or Problem Description
According to the reporter, postoperatively, of an laparoscopic appendectomy procedure, when the device used to close the appendix, t here was a release or the loops loosened for the three synthetic ligature loops due to the appendectomy, which resulted in peritonitis.It was noted that it was very painful for the patient.To resolve the issue, additional surgery for closure of the appendicular stump was done by stapling.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
According to the reporter, two days postoperatively of an laparoscopic appendectomy procedure, when the device was used to close the appendix, there was a release or the loops loosened for the three synthetic ligature loops due to the appendectomy which resulted in peritonitis.It was noted that it was very painful for the patient.To resolve the issue, additional surgery for closure of the appendicular stump was done by stapling.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGITIE
Common Device Name
SUTURE, ABSORBABLE, NATURAL
Manufacturer (Section D)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DR  0101
Manufacturer (Section G)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DR   0101
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key18891244
Report Number9612501-2024-00763
Device Sequence Number7477118
Product Code GAL
UDI-Device Identifier10884521099630
UDI-Public10884521099630
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K904588
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberEL-21-L
Device Catalogue NumberEL-21-L
Device Lot NumberJ3G2671Y
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Supplement Date Received by Manufacturer03/20/2024
05/28/2024
Initial Report FDA Received Date03/12/2024
Supplement Report FDA Received Date04/12/2024
06/07/2024
Date Device Manufactured07/26/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PLEASE SEE NOTE ON H11
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-